Florac
Florac is a Paris-based, Meyer family-owned permanent-capital private investment firm founded in 2009 that invests €20-70M tickets as majority or reference minority shareholder in mid-market companies across Europe and North America through its three poles — Florac Mid-Market Europe, Florac Partners Europe, and Florac North America — having supported more than 30 portfolio companies to date.
- Company typePrivate
- Founded2009
- HeadquartersParis, France
- Headcount11–50
- GTM typeB2B
- OfferingServices
What Florac does
Florac is a privately held, family-owned permanent-capital investment company founded in 2009 by Léopold Meyer and headquartered in Paris, with a North American office established in Los Angeles in 2016. The firm invests as a majority or reference minority (above 20% of capital) shareholder in mid-market companies with EBITDA of €5-30M in France and Western Europe, with €20-70M equity tickets, and in larger Western European and US/Canadian businesses via parallel vehicles. Operations are organized through three investment poles — Florac Mid-Market Europe, Florac Partners Europe, and Florac North America — supported by a Strategic Council of experienced independent members. Since inception, Florac has accompanied more than 30 companies across services (landscaping, certification, education, distribution, hospitality, engineering, healthcare, financial services), consumer goods (ready-to-wear, spirits), and industry (agri-food, specialty chemicals, health products), with notable realizations including Sani/Ikos (sold to GIC in 2022), Maison Herez (merged with Cyrus in 2024), and Groupe Delcourt (sold to Editis in 2024).
The firm employs 15 investment professionals (in Paris and Los Angeles) drawn from Lazard, Wendel, Moelis, Goldman Sachs, Crédit Suisse, ING, Barclays, J.P. Morgan, Houlihan Lokey, Deloitte, BNP Paribas and other tier-one institutions; core leadership includes Founder/President Léopold Meyer (Columbia), Florac North America Founder Camilla Meyer-Winkler (Georgetown), and Managing Partners Gautier Preney, Patrick Bendahan, Nicolas Teboul, and Anish Aswani. The Meyer family retains control through a Supervisory Committee and Investment Committee. Revenue model is investment-driven (capital gains, dividends, value-creation gains on exits) rather than fee-based; the registered entity Florac Investissements SAS carries €83.96M of capital and more than €800M has been invested in equity since 2009. Distribution is by direct negotiation with founders and management teams, supported by a referral network of co-investors (KKR, Goldman Sachs, Oaktree, Wendel, IK Investment Partners, Ardian, Bpifrance, Antin, Five Arrows, Peninsula, EMZ among others) and the related Experienced Capital operational investment platform.
Florac firmographics
Firmographics- Name
- Florac
- Legal name
- Florac Investissements
- Website
- https://florac.eu
- Company type
- Private
- Founded year
- 2009
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Florac is a Paris-based, Meyer family-owned permanent-capital private investment firm founded in 2009 that invests €20-70M tickets as majority or reference minority shareholder in mid-market companies across Europe and North America through its three poles — Florac Mid-Market Europe, Florac Partners Europe, and Florac North America — having supported more than 30 portfolio companies to date.
- Ownership category
- akta.pro rank
Florac industry classification
Industry- Product category
- Private Equity / Mid-Market Investment
- SIC
- Investment Advice (6282), Services-Engineering, Accounting, Research, Management (8700)
- akta.pro primary industry
- Corporate Strategic Partnership & Ecosystem Investment Arms (FSANAHAF)
Keywords
Where Florac is headquartered
LocationHeadquarters
- HQ city
- Paris
- HQ country
- France
- HQ region
- Europe
Offices2 records
Markets served
Florac business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Infrastructure, Technology or R&D, Others
Revenue model
- Private Equity Returns: Florac generates returns through capital gains on exits of portfolio companies, dividend distributions, and value creation through strategic support and operational improvements during the investment period.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels2 records
Florac product offering
Product offeringCore offering
Florac is a permanent-capital investment company that acquires majority or minority equity stakes in mid-market companies (typically 20–70M€ equity tickets) across Europe and North America. It supports entrepreneurs with capital, strategic guidance, and access to a network of expert advisors, with a typical investment horizon of 4–8 years, focused on services, consumer goods, and industrial sectors with solid growth drivers.
Product overview
Florac is a permanent capital investment company (societe d'investissement a capitaux permanents) active in Europe and North America, founded and owned by the Meyer family. The company operates through three complementary investment poles: Florac Mid-Market Europe (targeting mid-sized companies in France and Western Europe), Florac Partners Europe (targeting larger European companies), and Florac North America (targeting US and Canadian companies). Since its creation in 2009, Florac has accompanied more than 30 companies as majority or minority shareholder, focusing on services, consumer goods, and industrial sectors.
Differentiator
Problem solved
Functional benefit
Brands
- Florac Mid-Market Europe: Investment strategy targeting France and Western Europe with EBITDA of 5-30M€
- Florac Partners Europe
- Florac North America
Products and services
- Florac Mid-Market Europe Investment strategy targeting companies in France and Western Europe with EBITDA of 5–30M€, focusing on services (B2B, B2C), consumer goods, and industry sectors. Invests 20–70M€ of equity with a 4–8 year horizon, taking majority or reference minority positions (>20% capital).
- Florac Partners Europe Investment strategy targeting companies in France and Western Europe with EBITDA >30M€, taking minority positions alongside other financial or family investors.
- Florac North America Investment strategy targeting companies in the United States and Canada with EBITDA >5M$, investing 20–70M$ of equity in minority or majority positions alongside other financial or family actors.
Quantifiable outcome
- Supported >30 companies in Europe and North America since 2009
- +1 more outcomes
Companies that use Florac
Customer profileSegments1 record
Ideal customer profiles3 records
Florac technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Florac partnerships and signals
Strategic signalScale indicators4 records
Recent moves6 records
Expansion highlights5 records
Florac competitors and assessment
Company assessmentDirect peers
- Wendel: French family-controlled listed investment company with a multi-decade permanent capital model; directly comparable to Florac in strategy (long-hold, family-owned, focused on mid/large European companies) and scale (billions of AUM). Patrick Bendahan spent ten years at Wendel before joining Florac.
- Ardian: Paris-headquartered global private investment house with strong mid-market buyout, co-investment and secondary funds. Florac has actively co-invested alongside Ardian (e.g., Brico Privé), making it a directly comparable French mid-market partner.
- PAI Partners: Paris-based mid-market focused PE firm with a track record investing in French and Western European SMEs and family-owned companies across services, consumer, and industrial sectors. Comparable in deal-size band and sector mix to Florac Mid-Market Europe.
- Eurazeo: One of the largest publicly listed European PE/Private Debt firms headquartered in Paris, investing across mid-market buyouts in services, consumer, healthcare and technology. Directly comparable to Florac in geography, sector focus, and ticket size range, with much greater AUM.
- Dentressangle Capital: French mid/large-market PE firm with permanent-capital-style holding structure; co-invested with Florac on Marle. Comparable in mid-market European focus and family-controlled posture.
- Chequers Capital: French mid-market PE firm that has been Florac's co-investor on multiple deals (e.g., Groupe TCR). Operates in the same European mid-market space with comparable ticket sizes.
- IK Investment Partners: European mid-market PE firm focused on Northern Europe; co-investor with Florac on Marle (2019). Comparable in deal size, sector focus, and minority/majority approach.
Broad incumbents
- Bridgepoint: European mid-market PE firm investing across multiple sectors including services, consumer, healthcare. Comparable in geographic reach and mid-market ticket size, though much larger than Florac.
- Bpifrance: French state-owned public investment bank with deep mid-market PE and VC activities. Florac has been a co-investor with Bpifrance (e.g., ClubFunding) — both target French SMEs but Bpifrance operates at massively greater scale and across more sectors/stages.
- L Catterton: Large LVMH-affiliated consumer-focused PE firm investing globally across mid/large consumer brands. Overlaps with Florac's brand/consumer exposure (A.P.C., Fusalp, Samson & Surrey).
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
Florac social profiles
Digital presenceFlorac financial estimates
Financial estimateRevenue estimate
Valuation estimate
Florac leadership team
Management profileNumber of profiles
Profiles15 records
Florac subsidiaries and ownership
Company hierarchySubsidiaries3 records
Florac funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Florac M&A and investment
M&A and investmentM&A5 records
Investments8 records
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Florac
What does Florac do?
Florac is a permanent-capital investment company that acquires majority or minority equity stakes in mid-market companies (typically 20–70M€ equity tickets) across Europe and North America. It supports entrepreneurs with capital, strategic guidance, and access to a network of expert advisors, with a typical investment horizon of 4–8 years, focused on services, consumer goods, and industrial sectors with solid growth drivers.
Is Florac a public or private company?
Florac is a private company. It is classified as family owned and is currently operating.
When was Florac founded?
Florac was founded in 2009. It employs 11 to 50 people.
Where is Florac based?
Florac is headquartered in Paris, France, in the Europe region.
How does Florac make money?
One revenue line is on record: private Equity Returns.
Who are Florac's main competitors?
Direct peers on record are Wendel, Ardian, PAI Partners, Eurazeo, Dentressangle Capital, Chequers Capital and IK Investment Partners. Broad incumbents are Bridgepoint, Bpifrance and L Catterton.
Does Florac have an API?
No public API is recorded for Florac.
What industry is Florac in?
Florac's product category is Private Equity / Mid-Market Investment. Its primary akta.pro industry code is FSANAHAF, Corporate Strategic Partnership & Ecosystem Investment Arms. Its SIC code is 6282.